Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 076619
Company: HIKMA

Products on ANDA 076619

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
IFOSFAMIDE	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE;INJECTION	Prescription	AP	No	No
IFOSFAMIDE	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE;INJECTION	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 076619

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/29/2011	ORIG-1	Approval				Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/28/2020	SUPPL-7	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 076619

IFOSFAMIDE

INJECTABLE;INJECTION; 1GM/20ML (50MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
IFOSFAMIDE	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	076619	HIKMA
IFOSFAMIDE	IFOSFAMIDE	1GM/20ML (50MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	076657	MEITHEAL

INJECTABLE;INJECTION; 3GM/60ML (50MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
IFOSFAMIDE	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	076619	HIKMA
IFOSFAMIDE	IFOSFAMIDE	3GM/60ML (50MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	076657	MEITHEAL